This article relies largely or entirely on a single source .(May 2024) |
![]() | |
Names | |
---|---|
IUPAC name 1-(2-Methoxyphenoxy)-3-(propan-2-ylamino)propan-2-ol | |
Other names (±)-Moprolol | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
ECHA InfoCard | 100.024.777 |
EC Number |
|
MeSH | C009976 |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C13H21NO3 | |
Molar mass | 239.315 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Moprolol is a beta-adrenergic antagonist, or beta blocker. It is typically prescribed to treat hypertension, high blood pressure, angina pectoris, arrhythmias, anxiety, and glaucoma. [1]
Moprolol is currently off the market, most likely due to the manufacturer being in violation of US good manufacturing practices. [1]